Celldex Therapeutics (CLDX) Metrics: History & Chart

Celldex Therapeutics, Inc.(CLDX)

Biotechnology · Hampton, NJ

$30.96-1.64 (-5.02%)

Delayed quote: Oct 6, 2026, 12:45 PM EDT

About Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc. is a biopharmaceutical company dedicated to developing antibody-based treatments, specifically monoclonal and bispecific antibodies, for a range of diseases. Their pipeline features therapeutic candidates aimed at both inflammatory conditions and various forms of cancer. Among their key clinical programs: CDX-0159 is a Phase I monoclonal antibody designed to bind to and inhibit the activity of the KIT receptor tyrosine kinase. CDX-1140 is a human agonist monoclonal antibody that targets CD40, a critical immune response activator found on immune cells such as dendritic cells, macrophages, and B cells, as well as on several cancer cell types. CDX-527 is a bispecific antibody that integrates Celldex's proprietary anti-PD-L1 and CD27 human antibodies. Its mechanism involves combining CD27 costimulation with blockade of the PD-L1/PD-1 pathway to prime and activate anti-tumor T-cell responses. The company has established several research collaborations and licensing agreements, including partnerships with the University of Southampton for developing human antibodies targeting CD27, Amgen Inc. for exclusive rights to CDX-301 and CD40 ligand, and Yale University. Incorporated in 1983, Celldex Therapeutics, Inc. is headquartered in Hampton, New Jersey.

Hampton, NJ

198 employees

www.celldex.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Anthony S. Marucci

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+3.49%
30D Total Return	-17.87%
YTD Total Return	+19.99%
1Y Total Return	+23.40%
3Y Total Return	+18.27%
5Y Total Return	-41.86%
10Y Total Return	-50.49%
15Y Total Return	-4.26%
20Y Total Return	-87.51%

2026	+19.99%
2025	+7.48%
2024	-36.28%
2023	-11.02%
2022	+15.35%
2021	+120.55%
2020

CAGR TTM	+23.28%
CAGR 3Y	+5.75%
CAGR 5Y	-10.28%
CAGR 10Y	-6.79%
CAGR 15Y	-0.29%
CAGR 20Y	-9.88%

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

CLDX Valuation Metrics

CLDX Stock Price Metrics

CLDX Dividend Metrics

CLDX Growth Rate Metrics

CLDX Discounted Cash Flow Metrics

CLDX Returns By Period

CLDX Yearly Returns

CLDX Average Annual Returns By Period (CAGR)

CLDX Revenue Metrics

CLDX PE Ratio Metrics

CLDX PS Ratio Metrics

CLDX PB Ratio Metrics

CLDX Price to Free Cash Flow Ratio Metrics

CLDX Debt to Equity Ratio Metrics

CLDX PEG Ratio Metrics

CLDX FCF Yield

CLDX Earnings Yield

CLDX EBITDA Yield

CLDX OCF Yield

CLDX EV/EBIT Ratio Metrics

CLDX EV/EBITDA Ratio Metrics

CLDX EV/Assets Ratio Metrics

CLDX EV/Sales Ratio Metrics

CLDX Current Ratio Metrics

CLDX Quick Ratio Metrics

CLDX ROIC Metrics

CLDX Return on Assets Metrics

CLDX Return on Equity Metrics

CLDX Net Profit Margin Metrics

CLDX Gross Profit Margin Metrics

CLDX Tax Rate Metrics

PS Ratio	22650.05
PS Ratio Avg TTM	1418.51
PS Ratio Avg 3Y	343.72
Current VS TTM Avg	+1496.75%
Current VS 3Y Avg	+6489.77%
Current VS 5Y Avg	+5851.26%

PB Ratio	3.55
PB Ratio Avg TTM	3.81
PB Ratio Avg 3Y	3.46
Current VS TTM Avg	-6.80%
Current VS 3Y Avg	+2.63%
Current VS 5Y Avg	-8.15%

PFCF Ratio	6.89
PFCF Ratio Avg TTM	9.00
PFCF Ratio Avg 3Y	8.54
Current VS TTM Avg	-23.47%
Current VS 3Y Avg	-19.30%
Current VS 5Y Avg	-19.30%

Debt/Equity Ratio	0.01
Debt/Equity Ratio Avg TTM	0.00
Debt/Equity Ratio Avg 3Y	0.00
Current VS TTM Avg	+40.17%
Current VS 3Y Avg	+51.70%
Current VS 5Y Avg	-7.09%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	14.51%
FCF Yield Avg TTM	11.85%
FCF Yield Avg 3Y	12.61%
Current VS TTM Avg	+22.49%
Current VS 3Y Avg	+15.03%
Current VS 5Y Avg	+15.03%

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	4131.04
Ev/Ebit Ratio Avg TTM	4584.86
Ev/Ebit Ratio Avg 3Y	4584.86
Current VS TTM Avg	-9.90%
Current VS 3Y Avg	-9.90%
Current VS 5Y Avg	-9.90%

Ev/Ebitda Ratio	622.58
Ev/Ebitda Ratio Avg TTM	238.50
Ev/Ebitda Ratio Avg 3Y	45.68
Current VS TTM Avg	+161.04%
Current VS 3Y Avg	+1262.84%
Current VS 5Y Avg	+1262.84%

Ev/Assets Ratio	3.19
Ev/Assets Ratio Avg TTM	3.41
Ev/Assets Ratio Avg 3Y	3.13
Current VS TTM Avg	-6.47%
Current VS 3Y Avg	+2.00%
Current VS 5Y Avg	-9.06%

Ev/Sales Ratio	22270.14
Ev/Sales Ratio Avg TTM	1397.29
Ev/Sales Ratio Avg 3Y	333.69
Current VS TTM Avg	+1493.81%
Current VS 3Y Avg	+6573.83%
Current VS 5Y Avg	+5874.95%

Current Ratio	11.82
Current Ratio Avg TTM	12.78
Current Ratio Avg 3Y	17.66
Current VS TTM Avg	-7.51%
Current VS 3Y Avg	-33.04%
Current VS 5Y Avg	-36.64%

Quick Ratio	11.82
Quick Ratio Avg TTM	12.78
Quick Ratio Avg 3Y	17.66
Current VS TTM Avg	-7.51%
Current VS 3Y Avg	-33.04%
Current VS 5Y Avg	-36.64%

ROIC	(45.19%)
ROIC Avg 3Y	(38.26%)
ROIC Avg 5Y	(34.22%)
Current VS 3Y Avg	-18.13%
Current VS 5Y Avg	-32.07%
Current VS 10Y Avg	-23.36%

ROA	(38.42%)
ROA Avg TTM	(11.45%)
ROA Avg 3Y	(8.98%)
Current VS TTM Avg	-235.52%
Current VS 3Y Avg	-327.81%
Current VS 5Y Avg	-395.58%

ROE	(42.07%)
ROE Avg TTM	(44.26%)
ROE Avg 3Y	(34.42%)
Current VS TTM Avg	+4.96%
Current VS 3Y Avg	-22.22%
Current VS 5Y Avg	-32.26%

Net Profit Margin	(268385.71%)
Net Profit Margin Avg TTM	(194980.93%)
Net Profit Margin Avg 3Y	(5823.90%)
Current VS TTM Avg	-37.65%
Current VS 3Y Avg	-4508.35%
Current VS 5Y Avg	-3776.61%

Gross Profit Margin	100.00%
Gross Pft Margin Avg TTM	(2543.49%)
Gross Pft Margin Avg 3Y	(2468.25%)
Current VS TTM Avg	+103.93%
Current VS 3Y Avg	+104.05%
Current VS 5Y Avg	+102.73%

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A